UPPER

About UPPER

Shanghai Upper Bio-Tech Pharma Co., Ltd. is a high-tech enterprise specializing in point-of-care testing (POCT), which involves diagnostic testing performed at or near the site of patient care. The company's operations span research and development, manufacturing of reagent kits, production of in-vitro diagnostic (IVD) devices, and sales. It is situated in the Zhangjiang High-tech Park in Shanghai, a hub for medical device innovation.

The company was established on August 29, 1994, with Xu Jianxin as a key founder and its legal representative. Xu has a background in medical laboratory science, having worked at the Shanghai Second Lung Hospital and the Shanghai Institute of Plant Physiology, Chinese Academy of Sciences. The founding team, led by Xu, began its journey in the Zhangjiang Torch Business Incubator in 2001, transitioning from a sales agent to a research-driven enterprise. A significant milestone was achieved in 2016 when the company partnered with Orbimed, a global healthcare investment firm.

Upper Bio-Tech's business model is centered on the production and sale of POCT instruments and diagnostic reagents. The company serves the medical and healthcare industry, providing tools for rapid diagnostics. Its product line includes diagnostic kits for various conditions and automated analyzers. One of its notable developments is the SAA quantitative test kit, which helps in differentiating between bacterial and viral infections. The company has established five core technology platforms, including digital bio-information image detection and time-resolved fluorescence technology, supported by nearly 100 independent intellectual property rights.